DE60023020T2 - Positive modulatoren von nicotinrezeptor-agonisten - Google Patents
Positive modulatoren von nicotinrezeptor-agonisten Download PDFInfo
- Publication number
- DE60023020T2 DE60023020T2 DE60023020T DE60023020T DE60023020T2 DE 60023020 T2 DE60023020 T2 DE 60023020T2 DE 60023020 T DE60023020 T DE 60023020T DE 60023020 T DE60023020 T DE 60023020T DE 60023020 T2 DE60023020 T2 DE 60023020T2
- Authority
- DE
- Germany
- Prior art keywords
- receptor agonists
- nicotine receptor
- positive modulators
- modulators
- positive
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9903996A SE9903996D0 (sv) | 1999-11-03 | 1999-11-03 | New compounds |
| PCT/SE2000/002149 WO2001032620A1 (en) | 1999-11-03 | 2000-11-01 | Positive modulators of nicotinic receptor agonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60023020D1 DE60023020D1 (de) | 2006-02-16 |
| DE60023020T2 true DE60023020T2 (de) | 2006-06-14 |
Family
ID=20417606
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60023020T Expired - Fee Related DE60023020T2 (de) | 1999-11-03 | 2000-11-01 | Positive modulatoren von nicotinrezeptor-agonisten |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6756398B1 (enExample) |
| EP (1) | EP1230217B1 (enExample) |
| JP (1) | JP2003513072A (enExample) |
| AR (1) | AR026286A1 (enExample) |
| AT (1) | ATE305925T1 (enExample) |
| AU (1) | AU1745501A (enExample) |
| CO (1) | CO5280192A1 (enExample) |
| DE (1) | DE60023020T2 (enExample) |
| SE (1) | SE9903996D0 (enExample) |
| WO (1) | WO2001032620A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
| SE0202598D0 (sv) * | 2002-09-02 | 2002-09-02 | Astrazeneca Ab | Alpha-7 Nicotinic receptor agonists and statins in combination |
| US20070134169A1 (en) * | 2005-12-11 | 2007-06-14 | Rabinoff Michael D | Methods for smoking cessation or alcohol cessation or other addiction cessation |
| US8383657B2 (en) | 2007-12-21 | 2013-02-26 | Abbott Laboratories | Thiazolylidine urea and amide derivatives and methods of use thereof |
| TWI519532B (zh) | 2010-05-17 | 2016-02-01 | 艾維沃製藥公司 | （Ｒ）－７－氯－Ｎ－（啶－３－基）苯並［b］噻吩－２－羧醯胺鹽酸鹽單水合物之結晶形體 |
| RU2017136693A (ru) | 2012-05-08 | 2019-02-08 | Форум Фармасьютикалз, Инк. | Способы поддержания, лечения или улучшения когнитивной функции |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2731223A1 (fr) * | 1995-03-02 | 1996-09-06 | Pf Medicament | Nouveaux derives bi-tryptaminiques, leur procede de preparation et leur utilisation a titre de medicaments |
| EP1083918A1 (en) | 1998-06-08 | 2001-03-21 | Advanced Medicine, Inc. | Novel therapeutic agents that modulate 5-ht receptors |
-
1999
- 1999-11-03 SE SE9903996A patent/SE9903996D0/xx unknown
-
2000
- 2000-10-27 AR ARP000105701A patent/AR026286A1/es unknown
- 2000-11-01 WO PCT/SE2000/002149 patent/WO2001032620A1/en not_active Ceased
- 2000-11-01 JP JP2001534772A patent/JP2003513072A/ja not_active Abandoned
- 2000-11-01 DE DE60023020T patent/DE60023020T2/de not_active Expired - Fee Related
- 2000-11-01 US US10/111,028 patent/US6756398B1/en not_active Expired - Fee Related
- 2000-11-01 CO CO00083138A patent/CO5280192A1/es not_active Application Discontinuation
- 2000-11-01 AU AU17455/01A patent/AU1745501A/en not_active Abandoned
- 2000-11-01 EP EP00980158A patent/EP1230217B1/en not_active Expired - Lifetime
- 2000-11-01 AT AT00980158T patent/ATE305925T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AR026286A1 (es) | 2003-02-05 |
| US6756398B1 (en) | 2004-06-29 |
| CO5280192A1 (es) | 2003-05-30 |
| JP2003513072A (ja) | 2003-04-08 |
| WO2001032620A1 (en) | 2001-05-10 |
| EP1230217B1 (en) | 2005-10-05 |
| SE9903996D0 (sv) | 1999-11-03 |
| DE60023020D1 (de) | 2006-02-16 |
| AU1745501A (en) | 2001-05-14 |
| ATE305925T1 (de) | 2005-10-15 |
| EP1230217A1 (en) | 2002-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20022105D0 (no) | Positive modulatorer av nikotinreseptoragonister | |
| NO20022009D0 (no) | Positive modulatorer av nikotiniske reseptoragonister | |
| CY2012029I1 (el) | Νεα μορφη της s-ομεπραζολης | |
| EE05584B1 (et) | Glkokortikoidretseptori modulaatorid | |
| ID24481A (id) | Gastrokinetik monosiklik benzamida dari derivat-3-atau-tersubstitusi 4-(aminometil)-piperidin | |
| NO20013183D0 (no) | Azabicykloalkaner som CCR5-modulatorer | |
| NO20016116D0 (no) | Substituerte heterocykliske fuserte gamma-karboliner | |
| NO996440D0 (no) | Omeprazol-natriumsalt | |
| EE200200355A (et) | EP4 retseptori selektiivsed agonistid osteoporoosi raviks | |
| FI991485A0 (fi) | Uusi farmaseuttinen koostumus | |
| IS5245A (is) | Lyfjablanda úr ómeprasól | |
| DE69719191D1 (de) | Tetrahydroisoquinoline derivate als modulatoren von dopamine d3 rezeptoren | |
| EE200100395A (et) | (S)-omeprasooli kaaliumisool | |
| NO20013456D0 (no) | Funksjonaliserte heterocykler som chemokin-reseptor- modulatorer | |
| DE60028368D1 (de) | Agonisten des peroxisom aktivator-responsiven rezeptors | |
| DE60023020D1 (de) | Positive modulatoren von nicotinrezeptor-agonisten | |
| ATE254929T1 (de) | Oralverabreichbare lösung von prucaloprid | |
| ID30056A (id) | Agonis-agonis 5-htif | |
| DE69903627D1 (de) | Tetrahydroisochinolinderivate als modulatoren von dopamin d3 rezeptoren | |
| ID30381A (id) | Penggunaan arilalkanoilpiridazina | |
| FR2798731B1 (fr) | Gyroscope vibrant | |
| NO20022142L (no) | Anvendelse av dopamin-D3 reseptor agonister for behandling av saltavhengig hypertensjon | |
| DE69825688D1 (de) | Einrichtung zur Trocknung von Zucker | |
| SE9903009D0 (sv) | Use of new responsive elements | |
| SE9904269D0 (sv) | Use of new responsive elements |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |